AAIC 2025 Abstract
The Swiss OMICS‐AD multimodal biomarker cohort study: design, methods, and cohort characteristics
Study in peopleAI & data
Abstract
Background: Besides amyloid pathology and tau‐related neurodegeneration, multiple other molecular alterations and pathway dysregulations have been observed in Alzheimer's disease (AD).
